Finally upgraded
December 8, 2010
after all these years… it wasn’t so bad
Women in the Workplace… It Pays to be Thin
October 7, 2010
10/7/10
CNBC
Women’s Weight and Salary: Study on weight and salary
WOMEN:
Very thin women = higher pay {avg. $15,000 more)
More weight = smaller salary
MEN:
Just the opposite…
NOTE: It’s enough to make a gal angry. ~ Gigi
Technorati Tags:
Abdominal Obesity, Weight and Career
Social Networks in the Real World a Theoretical Basis for Weight Gain
September 23, 2010
I saw a 5 minutes explanation of this theory connected to weight gain and didn’t think to post it here. It has actually made me think about my interaction with food and family/friends.
If I find the other link, I’ll add it. Someday I’ll make a simple little tutorial around this concept.
Best, Gigi
How to Keep Muscles Young: Eat Less Food
August 6, 2010
Technology Review
How to Keep Muscles Young: Eat Less Food
Caloric restriction and exercise slow muscle decline in mice.
By Emily Singer
FRIDAY, AUGUST 06, 2010
The connections between your nerves and muscle deteriorate with age–a phenomenon that may help explain the serious loss of muscle that often strikes old people. New evidence suggests that caloric restriction–a nutritionally complete but low-calorie diet–could help prevent these changes. According to a study published this week, a very-low-calorie diet, and to a lesser extent exercise, can prevent or slow some aspects of muscle decline in aging mice.
Obesity: How Intestinal Bacteria May Cause Weight Gain
March 5, 2010
Obesity: How Intestinal Bacteria May Cause Weight Gain – Yahoo! News
Obesity: How Intestinal Bacteria May Cause Weight Gain
If you’re fighting the battle of the bulge, most of your attention – and frustration – is probably aimed at your midsection. It makes sense, since that’s where the extra pounds tend to gravitate, especially with the creep of middle age, piling on to form that dreaded spare tire.
But a growing body of research suggests there’s another, less visible reason to focus on your gut if you want to lose weight. Scientists led by Andrew Gewirtz at Emory University reveal that your intestines harbor a universe of bacteria – the so-called gut microbiota – that may play an important role in whether your body will store the food you eat as extra pounds.
Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications — Cooper-DeHoff et al. 55 (1): 61 — Hypertension
January 7, 2010
Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications — Cooper-DeHoff et al. 55 (1): 61 — Hypertension
Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications
Rhonda M. Cooper-DeHoff; Sheron Wen; Amber L. Beitelshees; Issam Zineh; John G. Gums; Stephen T. Turner; Yan Gong; Karen Hall; Vishal Parekh; Arlene B. Chapman; Eric Boerwinkle; Julie A. Johnson
From the Colleges of Pharmacy (R.M.C.-D., S.W., J.G.G., Y.G., J.A.J.) and Medicine (R.M.C.-D., J.G.G., K.H., J.A.J.) and Center for Pharmacogenomics (R.M.C.-D., S.W., J.G.G., Y.G., J.A.J.), University of Florida, Gainesville, Fla; School of Medicine (A.L.B.), University of Maryland, Baltimore, Md; US Food and Drug Administration (I.Z.), Silver Spring, Md; Mayo Clinic College of Medicine (S.T.T.), Rochester, Minn; Morehouse School of Medicine (V.P.), Atlanta, Ga; School of Medicine (A.B.C.), Emory University, Atlanta, Ga; Human Genetics Center and Institute of Molecular Medicine (E.B.), University of Texas at Houston, Houston, Tex.
Correspondence to Rhonda M. Cooper-DeHoff, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, 1600 SW Archer Rd, Box 100486, Gainesville, FL 32610-0486. E-mail dehoff@cop.ufl.edu
We assessed adverse metabolic effects of atenolol and hydrochlorothiazide among hypertensive patients with and without abdominal obesity using data from a randomized, open-label study of hypertensive patients without evidence of cardiovascular disease or diabetes mellitus. Intervention included randomization to 25 mg of hydrochlorothiazide or 100 mg of atenolol monotherapy followed by their combination. Fasting glucose, insulin, triglycerides, high-density lipoprotein cholesterol, and uric acid levels were measured at baseline and after monotherapy and combination therapy. Outcomes included new occurrence of and predictors for new cases of glucose ≥100 mg/dL (impaired fasting glucose), triglyceride ≥150 mg/dL, high-density lipoprotein ≤40 mg/dL for men or ≤50 mg/dL for women, or new-onset diabetes mellitus according to the presence or absence of abdominal obesity. Abdominal obesity was present in 167 (58%) of 395 patients. Regardless of strategy, in those with abdominal obesity, 20% had impaired fasting glucose at baseline compared with 40% at the end of study (P<0.0001). Proportion with triglycerides ≥150 mg/dL increased from 33% at baseline to 46% at the end of study (P<0.01). New-onset diabetes mellitus occurred in 13 patients (6%) with and in 4 patients (2%) without abdominal obesity. Baseline levels of glucose, triglyceride, and high-density lipoprotein predicted adverse outcomes, and predictors for new-onset diabetes mellitus after monotherapy in those with abdominal obesity included hydrochlorothiazide strategy (odds ratio: 46.91 [95% CI: 2.55 to 862.40]), female sex (odds ratio: 31.37 [95% CI: 2.10 to 468.99]), and uric acid (odds ratio: 3.19 [95% CI: 1.35 to 7.52]). Development of adverse metabolic effect, including new-onset diabetes mellitus associated with short-term exposure to hydrochlorothiazide and atenolol was more common in those with abdominal obesity.
Key Words: atenolol • hydrochlorothiazide • abdominal obesity • metabolic syndrome • new-onset diabetes mellitus • hypertension
Technorati Tags:
Central Obesity: Risks of, Abdominal Obesity, Metabolic Syndrome
Obesity In Mid-Life Linked To Risk Of Frailty
May 30, 2009
Obesity among middle-age people increases the risk of illness and death later in life, according to Finnish researchers.
A team of researchers studied more than 1,000 men from age 25 to mid-70s and found that those who were overweight during their 40s followed by a period of weight loss were more susceptible to illness and death as they got older.
Writing in the European Heart Journal, researchers said that while obesity has been linked to risk of heart disease, other studies have shown that being overweight can actually help in situations of heart failure.
Posted on: Monday, 25 May 2009, 11:23 CDT
Here’s the article…
Microbe Composition In Gut May Hold Key To One Cause Of Obesity
January 20, 2009
Microbe Composition In Gut May Hold Key To One Cause Of Obesity
Microbe Composition In Gut May Hold Key To One Cause Of Obesity ScienceDaily (Jan. 20, 2009) — Biodesign Institute in collaboration with colleagues at the Mayo Clinic, Arizona, and the University of Arizona, reveal a tantalizing link between differing microbial populations in the human gut and body weight among three distinct groups: normal weight individuals, those who have undergone gastric bypass surgery, and patients suffering the condition of morbid obesity—a serious, often life-threatening condition associated with diabetes, cardiovascular disease, cancer and psychosocial disorders. Obesity affects around 4 million Americans and, each year, some 300,000 die from obesity-related illness.
Non-alcoholic Fatty liver disease: the new epidemic and the need for novel nutritional approaches.
January 12, 2009
Non-alcoholic Fatty liver disease: the new epidemic and the need for novel nutritional approaches.
J Med Food, Vol. 10, No. 4. (December 2007), pp. 563-565.
The epidemic of non-alcoholic fatty liver disease (NAFLD) in the United States is staggering, and there is an enormous void in our understanding of the clinical epidemiology other than the common themes of obesity and insulin resistance. There is also a public health need to better define effective treatments of NAFLD, including dietary interventions and appropriate nutritional supplements. There is, however, a wealth of basic science that helps to set the stage for defining the mechanisms leading to liver pathology. In this article we will attempt to put these concepts in perspective to highlight the need for future research including the use of medicinal food.
C Selmi, CL Bowlus, CL Keen, ME Gershwin
Weight-Loss Potions Have Hidden Surprises – Heart to Heart (usnews.com)
December 30, 2008
Weight-Loss Potions Have Hidden Surprises – Heart to Heart (usnews.com)
Weight-Loss Potions Have Hidden Surprises
December 23, 2008 04:44 PM ET | Bernadine Healy M.D. | Permanent Link | Print
The Food and Drug Administration is not the Grinch who stole Christmas for warning just before the holiday that a passel of weight loss drugs—28 to be exact, all currently available over the counter or on the Internet—can be dangerous to people’s health. In fact, the agency may be a health savior for lots of people who have been lulled into taking diet potions that might work but bear surprise ingredients, two of which are particularly concerning.
Technorati Tags:
Central Obesity Dieting
Science Based Metabolism Search:
Latest Headlines
- Finally upgraded
- Women in the Workplace… It Pays to be Thin
- Social Networks in the Real World a Theoretical Basis for Weight Gain
- How to Keep Muscles Young: Eat Less Food
- Obesity: How Intestinal Bacteria May Cause Weight Gain
- Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications — Cooper-DeHoff et al. 55 (1): 61 — Hypertension
- Obesity In Mid-Life Linked To Risk Of Frailty
- Microbe Composition In Gut May Hold Key To One Cause Of Obesity
- Non-alcoholic Fatty liver disease: the new epidemic and the need for novel nutritional approaches.
- Weight-Loss Potions Have Hidden Surprises – Heart to Heart (usnews.com)
